Alterations in CD31 expression or function are linked to several pathological conditions. For instance, reduced CD31 expression is associated with atherosclerosis and other cardiovascular diseases. In oncology, CD31 is used to identify angiogenesis in tumors, which can be indicative of metastatic potential and prognosis. Moreover, CD31 has been implicated in inflammatory diseases due to its role in leukocyte migration.
